個人積分：14322分
文章編號：83050737
莫德納這幾天沒有打幾針, 仍然2人疑似死亡
個人積分：1612分
文章編號：83052310
個人積分：3564分
文章編號：83052748
〔記者陳永吉／台北報導〕高端疫苗（6547）今日（9/22）公告，經兩個月來與歐盟EMA（歐洲藥品管理局）進行科學諮詢後，已取得EMA正面回應，高端COVID-19疫苗在歐盟之第三期臨床試驗，將規劃以多國多中心方式，與歐盟已上市之COVID-19疫苗進行免疫橋接比對試驗，目標盡快取得歐盟認證。
高端表示，今年6月由全球主要國家之法規單位所組成的「ICMRA國際藥物監管機構聯盟」，已於會議中達成以免疫橋接進行臨床試驗設計的目標共識。在ICMRA會議之後，日本藥政法規單位PMDA已核准日本第一三共藥廠，以免疫橋接方式執行三期試驗；韓國藥政法規單位MFDS，也在ICMRA會議後，核准韓國SK藥廠，以3990人規模，與AZ比較進行三期免疫橋接試驗。
而在日韓核准國內藥廠以免疫橋接執行COVID-19疫苗三期臨床試驗之前，法國疫苗廠Valneva，已經在今年4月21日於英國取得三期IND（臨床試驗申請）許可，並在6月3日完成招募4000名受試者招募，預期今年底Valneva將可取得全病毒去活化COVID-19疫苗VLA2001與AZ疫苗的免疫橋接三期期中分析數據。
除了日韓以外，由澳洲、加拿大、新加坡、瑞士、英國所組成的Access Consortium跨國醫藥聯盟，也在2021/09/16同時發表聯合聲明，表態支持ICMRA的會議結論，將以免疫橋接方式授權新的COVID-19疫苗。
個人積分：1294分
文章編號：83055146
個人積分：49分
文章編號：83055173
個人積分：1612分
文章編號：83055304
個人積分：1294分
文章編號：83055316
bd_player wrote:
只會比數字大小的人邏(恕刪)
你自己去查海洛英死多少人吧!
疫苗比海洛英還會殺人
也比病毒還厲害很多!
台中打疫苗後死亡有101人 確診死亡者20倍且無人獲理賠
先去幫台中人求償吧!
個人觀點喜歡就拿去用!用就是你的了!
個人積分：317分
文章編號：83057477
個人積分：980分
文章編號：83057663
因為FDA沒有批准
請參考就好
非洲使用伊維菌素的國家
顯著的降低COVID-19死亡與病例數
Why does Africa have such low rates of severe covid-19 infection and mortality?
https://www.planet-today.com/2021/09/why-does-africa-have-such-low-rates-of.html?m=1#gsc.tab=0
by Planet Today News Saturday, September 11, 2021 0 Comments
Planet Today) In 2015, the Nobel Prize in Physiology and Medicine was awarded to William C. Campbell from the US, Satoshi Omura from Japan, and Youyou Tu from China. The three scientists discovered natural-based remedies to treat parasitic infections that cause malaria, river blindness (onchocerciasis) and elephantiasis (lymphatic filariasis). These infections plague over a hundred million people annually, especially throughout Africa, where living conditions are less favorable.
(Article by Lance D Johnson republished from NaturalNews.com)
Youyou Tu was able to isolate and synthesize artemisinin from the herb, sweet wormwood (Artemisia annua). The discovery has led to a novel therapy against malaria. William Campbell and Satoshi Omura cultivated dozens of strains of streptomyces bacteria and isolated avermectin. Renamed ivermectin, this bacterium was made into a blockbuster drug and become a novel therapy against roundworm infections. Today, ivermectin is showing promise for covid patients, and even inhibits SARS-CoV-2, in vitro.
Ivermectin and artemisinin revolutionize medicine in Africa
Ivermectin and artemisinin have revolutionized the quality of life for millions of people living in Africa. The Nobel committee in Stockholm said artemisinin and ivermectin “treatment is so successful that these diseases are on the verge of eradication, which would be a major feat in the medical history of humankind.”
Now that these medicines are being used as front-line treatments in certain areas of Africa, fewer people are suffering from severe infections, which includes respiratory infections like covid-19. In April 2020, the journal Antiviral Research published an article promoting ivermectin because it showed early success in treating SARS-CoV-2. Since then, there have been 75 peer reviewed studies on ivermectin, with promising results. In 63 prophylaxis studies, ivermectin showed an 86% improvement for covid patients. In 45 peer reviewed early treatment studies, ivermectin showed a 70 percent improvement for covid patients.
Ivermectin drastically lowers mortality rate and case count for covid-19
The National Library of Medicine published a bombshell report in October 2020 showcasing all the countries that participated in the African Program for Onchocerciasis Control. Some countries took part in an “intensive Ivermectin mass campaign carried out to control onchocerciasis.” Other countries did not take part. The report compared covid-19 mortality and infection rates among these countries. The countries that deployed ivermectin had a peculiarly lower rate of infection — eight percent lower — but most importantly, these nations had a 28 percent lower covid-19 mortality rate! The mortality rate could be further reduced because this study represents incidental use of ivermectin, prescribed for something entirely different. What would the results be if ivermectin was prescribed early and often as a direct therapeutic for covid-19 and other respiratory infections?
Japanese researchers were curious about the ivermectin connection. They investigated thirty-one “onchocerciasis endemic” countries that used “community-directed treatment with ivermectin.” The researchers compared their COVID-19 statistics with 22 “non-endemic” countries. The mortality rate was “significantly less” in the thirty-one countries that used ivermectin for onchocerciasis. In the countries where ivermectin was used frequently, there were 134.4 cases per 100,000 people and the number of deaths was 2.2 per 100,000. In countries that do not use ivermectin, there are 950.6 cases per 100,000 and 29.3 deaths per 100,000. This realization prompted Tokyo’s Medical Association Chairman to hold a live press conference recommending ivermectin to all doctors and for all covid-19 patients.
FDA hesitant to regulate, dispense and recommend ivermectin, despite overwhelming evidence of efficacy
The U.S. Food and Drug Administration (FDA) has not moved forward with clinical studies on ivermectin, despite the drug’s historic efficacy against other pathogens. The agency maintains: “The FDA has not reviewed data to support use of ivermectin in COVID-19 patients to treat or to prevent COVID-19.”
If regulatory agencies were to admit that there are effective antiviral treatments that target viral proteins, then there would be no legal justification to grant emergency use authorization to experimental vaccines. But with ivermectin, early treatment saves lives. The drug is not only an over-the-counter veterinary-grade treatment for infections in horses. At the right dose and formulation, it can be used successfully to treat infections in humans. The FDA and other regulatory agencies, however, are hesitant to approve, regulate and dispense this medicine in a form that patients and hospitals can rapidly deploy with efficacy. Why is that? Shouldn’t a life-saving, affordable, effective medicine be a priority? With proper dispensing, ivermectin could be used in treatment protocols, without the risk of overdose.
Using treatments such as ivermectin is just the tip of the iceberg. There are several anti-inflammatory, anti-viral compounds that can improve survival rates and lessen suffering in medical systems around the world, if only the powers that be allowed it.
個人積分：14322分
文章編號：83072126
